opioid

Emergency departments across the United States experienced a surge in opioid overdose cases during the pandemic. Now, a program at VCU Health aims to help those patients receive the treatment they need after they leave the emergency department. The new VCU Health Virtual Bridge Clinic creates a direct link between the emergency department and treatment programs for patients with opioid use

No one wants to see a child in physical pain, but post-surgery treatment with opioids poses risks for addiction or other misuses. Surgeons have lacked effective guidance about prescribing opioids to manage a child’s pain after surgery. Now Lorraine Kelley-Quon, MD, MSHS, FACS, FAAP, (https://bit.ly/2StAqc6) a former SC CTSI KL2 Mentored Career Development Scholar, is helping to fill that knowledge

Even during the COVID-19 pandemic, opioid misuse has continued unabated in the United States, with an estimated 2.5 million or more Americans suffering from opioid use disorder. Most people treated for the disorder are given medications, such as buprenorphine, that activate opioid receptors. But there is disagreement about whether it’s safe to prescribe buprenorphine for people who also take

Neuropathic pain affects millions of Americans every year. This fact combined with the nationwide crisis of opioid misuse reinforces the need for safer and more effective therapies to help those suffering from chronic pain. In tandem with efforts from the National Center for Advancing Translational Sciences and in an effort to advance research in this arena, in 2017 the ICTS offered a new funding

To mitigate risk of COVID-19, two University of Minnesota (UMN) researchers are analyzing factors such as race, economic stability, living environment, education, and more to get a more comprehensive, holistic picture of health.

The Center for Evidence-based Policy at Oregon Health & Science University (OHSU) recently launched CLOUD: Curated Library about Opioid Use for Decision-makers. CLOUD is a user-friendly, online repository of evidence-based, actionable materials on opioids and the opioid crisis. The opioid library has three specific audiences in mind: payers & providers, policymakers & community leaders, and

Researchers at Virginia Commonwealth University this week were awarded two grants totaling more than $2.6 million through the National Institutes of Health Helping to End Addiction Long-term Initiative, or NIH HEAL Initiative, to improve treatment for opioid addiction. VCU’s School of Pharmacy, School of Medicine and C. Kenneth and Dianne Wright Center for Clinical and Translational Research will

A SC CTSI-supported study by Lorraine Kelley-Quon, MD, a pediatric surgeon at Children’s Hospital Los Angeles and assistant professor at the Keck School of Medicine of USC, found that teens who used opioid pills were more likely to try heroin.

Researchers from the University of North Carolina at Chapel Hill School of Medicine, the home of the North Carolina Translational and Clinical Sciences (NC TraCS) Institute, will collaborate with the North Carolina Department of Public Safety and the Durham County Sheriff’s Office to implement and evaluate two new opioid addiction treatment programs for people in the criminal justice system. Both

Research from Penn State Clinical and Translational Science Institute on the societal costs of the opiod epidemic is featured in a supplement from the The American Journal of Managed Care.The supplement will inform a variety of community audiences including policymakers. The supplement also explores the effect of the crisis on state governments, including the costs to employment and labor market

The University of Virginia (UVA) has received a multi-million dollar grant from the National Institutes of Health (NIH). Virginia Commonwealth University (VCU) in Richmond first received the same grant a year ago, paving the way for more medical research in Virginia. Winners of the NIH’s Clinical and Translational Science Awards are an elite group of research institutions. And now UVA and VCU are

Fentanyl is a deadly part of the opioid crisis. The synthetic drug can be up to 100-times more potent than morphine. Now researchers at Virginia Commonwealth University in Richmond have not only tested a promising vaccine, but they’ve also developed a method to test other new treatments. "We need every option we can possibly get to treat this epidemic because it’s killing so many Americans,” says

University of Illinois at Chicago CCTS-supported researcher, Dr. Katie Suda, was featured in U.S. News & World Report discussing her recent JAMA Network Open publication, which found that despite the nation's opioid epidemic, U.S. dentists are far more likely to prescribe addictive opioid painkillers than their British counterparts. We have all probably had the experience of a terrible toothache,"